Latest news
Intellia Therapeutics reports Q2 2026 net loss of $106.6M, $628.4M cash; positive Phase 3 data for lonvo-z - TradingViewTradingView · Thu, 06 Aug 2026 11:53:01 GMTIntellia Therapeutics Reports Positive Phase 3 HAELO Data for Lonvo-z, Advances Nex-z Trials and Reaffirms Cash Runway Into 2028 - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMTIntellia: Phase 3 HAELO Win Doesn't Fix The Commercial Problem - Seeking AlphaSeeking Alpha · Wed, 29 Jul 2026 07:00:00 GMTEarly Data Suggests Unspectacular Start for Halo on PS5 - Push SquarePush Square · Wed, 29 Jul 2026 07:00:00 GMT